Authors


Christine Blank

Latest:

Drug Price Hikes Already Found in 2023

List prices of 450 medications have increased 5% overall at the beginning of 2023. More price hikes are expected.


Marcella R. Aquino, MD, FACAAI

Latest:

Marcella R. Aquino, MD, FACAAI: Don’t Make a Rash Dx

Marcella R. Aquino details issues in differential diagnosis for rashes that mimic allergic skin conditions at the ACAAI Annual Meeting.


Matthew Reedy, MD

Latest:

Administrative Burden of Prescribing Biologics

Prescribing biologics can require a complex approval and claims process. Creating a tiered system based on office workload can help practices understand and allocate staff time. Outsourcing approvals to pharmacies where possible can also streamline the process.



Cheri N. Frey, MD

Latest:

Cheri Frey, MD, FAAD: Exploring Cosmeceutical Ingredients and Their Role in Skin Health

Frey discussed the role of various cosmeceuticals and ingredients in benefitting the skin health of patients, as well as insights into pairing OTC products with Rx.


Steve Feldman, MD, PhD

Latest:

Ensure Patient Adherence in Pediatric Atopic Dermatitis Cases

Steve Feldman, MD, PhD, is part of an atopic dermatitis panel and focuses on strategies to hold pediatric patients and their parents accountable to treatment methods.


Brittany Scurto, PA-C

Latest:

Brittany Scurto, PA-C: How to Discuss an Integrative Medicine Approach With Patients

Scurto presented integrative medicine pearls at the 2024 Diversity in Dermatology meeting.



Kamran H. Imam, MD

Latest:

Award Recipient to Focus on Atopic Dermatitis in Native Americans

Kamran H. Imam, MD, hopes to unlock insights into the atopic disease burden among Native American populations.



Logan Lutton

Latest:

Majority of state medical boards see increase in COVID-19 misinformation complaints against physicians

An alarming amount of COVID-19 disinformation is prevalent even from physicians.


Matthew Gavidia

Latest:

Study: Lifestyle Behaviors Linked With Psoriasis Development

Lifestyle behaviors, such as body mass index and smoking, were shown to have a stronger association with psoriasis, regardless of genetic risk.


Laura Ferris, MD, PhD

Latest:

Frontline Forum Part 4: Solutions in the Management and Treatment of Basal Cell Carcinoma

In part 4 of this Frontline Forum series, John M. Strasswimmer, MD, PhD; Andrew H. Weinstein, MD; Neal Bhatia, MD; Laura Ferris, MD; and Aaron S. Farberg, MD, discuss solutions for managing and treating patients with basal cell carcinoma.


Michael Cameron, MD, FAAD

Latest:

Enhancing Atopic Dermatitis Treatment: Insights From Cutting-Edge Studies and Clinical Perspectives Part 1

A 5-expert panel delves into atopic dermatitis guidelines and recommendations and recent studies to make note of.


Adel Haque, MD

Latest:

Managing Atopic Dermatitis Postpartum and While Breastfeeding

A patient returns to your clinic seeking systemic therapy for her AD while postpartum and breastfeeding. Test your knowledge on injectables.


Shawn Kwatra, MD

Latest:

Late-Breaking Data: Povorcitinib Significantly Improves Itch and Lesions in Prurigo Nodularis

Shawn Kwatra, MD, shares positive updates on phase 2 oral povorcitinib for prurigo nodularis at AAD 2024.


Jeff Bendix

Latest:

Burnout, Frustration Levels Continue to Grow Among Physicians

Doctors cite more support staff, reduced patient panels among solutions.


Terri L. Phillips, MD, FAAP

Latest:

Diverse Perspectives in Medical Aesthetics Matter More Than Ever

Dermatology Times® invites medical professionals in the dermatology community to speak out on the vital issues facing the specialty.



Stephen Zander, MBA

Latest:

How Can AI Improve Patient Care?

AI’s ability to quickly process and interpret large quantities of health data is a valuable tool for physicians.


Susan C. Olmstead, Editor

Latest:

Drug Combination May Benefit Patients with Transplanted Kidneys, Advanced Skin Cancers

In most kidney transplant recipients with advanced skin cancer, 2 checkpoint inhibitors are needed to boost the immune system, according to a new study.



Hope Mitchell, MD, FAAD

Latest:

Dermatology Times in France: What La Roche-Posay Products Dermatologists Recommend for Eczema, Acne

Dermatologists Jeanine Downie, DiAnne Davis, and Hope Mitchell reveal the La Roche-Posay products they recommend to patients with dry skin, eczema, and more, at the flagship store in France.


Daniel Siegel, MD

Latest:

Managing Dermatologic Surgery Challenges

Daniel Siegel, MD, shared strategies to manage surgery challenges, especially bleeding, to ensure a smooth experience for patients.


Gianna Melillo

Latest:

Study Underscores Need for More Effective Psoriasis Oral Therapies

Survey responses revealed the rates and times at which patients switched from oral to biologic therapies.


Nicholas Wrigley

Latest:

Data Support the Use of First-/Second-Line Immune Checkpoint Inhibitors in HNSCC

Findings from a retrospective cohort study found that immune checkpoint inhibitors induced promising responses in the first- and second-line treatment of head and neck squamous cell carcinoma.


Hadar Lev-Tov, MD

Latest:

Dermatologist Talks About the ABCs of Wounds and HS Support at Annual Meeting

Expert insights on the latest issues in wounds as well as HS resources are shared at the annual meeting.


Jeffrey Yager, MD

Latest:

Holistic Aesthetics Center to Host First Annual Symposium in Middletown, New York

Jeffrey Yager, MD, discusses the new SY Aesthetics campus that will integrate traditional and Chinese healing.


Sandra Fyfe

Latest:

Frontline Forum Part 4: Solutions in the Management and Treatment of Basal Cell Carcinoma

In part 4 of this Frontline Forum series, John M. Strasswimmer, MD, PhD; Andrew H. Weinstein, MD; Neal Bhatia, MD; Laura Ferris, MD; and Aaron S. Farberg, MD, discuss solutions for managing and treating patients with basal cell carcinoma.


Maggie L. Shaw

Latest:

Novel, Nonsurgical BCC Treatment Shown Safe and Effective

In this study, researchers treated 37 basal cell carcinoma (BCC) lesions from 30 patients, with follow-ups at 5 time points after baseline examination.

© 2024 MJH Life Sciences

All rights reserved.